TY  - JOUR
AU  - Ding, Ning
AU  - Zhang, Xilong
PY  - 2018
TI  - Transvenous phrenic nerve stimulation, a novel therapeutic approach for central sleep apnea
JF  - Journal of Thoracic Disease; Vol 10, No 3 (March 31, 2018): Journal of Thoracic Disease
Y2  - 2018
KW  - 
N2  - Central sleep apnea (CSA) is common in heart failure (HF) patients. Traditional treatment of CSA, including continuous positive airway pressure (CPAP), adaptive servo ventilation (ASV), oxygen therapy, and CO2 inhalation, has respective limitations. Transvenous phrenic nerve stimulation (PNS), a novel therapeutic approach for CSA, was proved to be effective and safe. The remedē® system and related transvenous PNS methods was approved by FDA in 2017, for treating moderate to severe CSA.
UR  - https://jtd.amegroups.org/article/view/19780